Introduction
Dengue virus (DENV) infection is a serious public health problem in tropical and subtropical areas, and it is estimated that approximately 390 million people are infected yearly (1) . DENV infection is associated with a range of clinical manifestations, from asymptomatic to life-threatening. More severe dengue disease presentations including dengue hemorrhagic fever and dengue shock syndrome are usually associated with heterotypic secondary infections with one of the four different serotypes (DENV1-DENV4) (2) , which is postulated to be at least partially mediated by non-neutralizing serotype cross-reactive antibodies that can lead to antibody-dependent enhancement of infection (3) (4) (5) .
The role of CD8 + T cells in dengue infection has been the subject of intense debate. Although some initial studies postulated that T cells may exacerbate the development of dengue diseases, subsequent studies indicate that T cells may have protective functions (6) (7) (8) . CD8 + T cells have been shown to mediate protection in murine models of DENV infection and vaccination (9) (10) (11) (12) , and CD8 + T cells can confer protection against heterotypic DENV infection and prevent antibody-dependent enhancement (13) (14) (15) . In humans, DENV-specific CD8 + T cells can migrate to the skin, and their frequency may be inversely correlated with disease severity (16, 17) . Notably, high-magnitude and polyfunctional DENV-specific CD8 + T cell responses are associated with protective HLA alleles against severe dengue disease in the general populations of Sri Lanka and Nicaragua, where DENV infection is highly endemic (18, 19) . The recently approved Dengvaxia vaccine was designed to induce humoral but not CD8 + T cell responses against DENV. However, its suboptimal efficacy, coupled with safety adverse events, signals that the need for an efficacious DENV vaccine is still unmet. Most importantly, these issues urge a better understanding of DENV-specific CD8 + T cell responses at the cellular and molecular levels. Surprisingly, the phenotypic and transcriptomic profiles of isolated human DENV-specific CD8 + T cell subsets have not yet been systematically interrogated. Some information exists related to the transcriptional signatures of whole blood and PBMCs in DENV-infected patients (23) (24) (25) (26) ; however, much less is known at the level of human T cells. Although transcriptomic analyses of human CD8 + T cells from DENV-infected patients have been conducted, in those studies the gene expression profiles were analyzed not at the level of antigen-specific CD8 + T cells, but at the level of activated CD8 + T cell populations (27) . Furthermore, little information exists at the level of CD8 + T cell subsets, such as Tcm, Tem, and Temra cells. This is particularly relevant as CD8 + Temra cells have been implicated in protection from viral pathogens such as HIV, cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza virus, and yellow fever virus in humans (28) (29) (30) (31) (32) . Thus, it is Accumulating evidence demonstrates that CD8 + T cells contribute to protection from severe dengue virus (DENV) disease and vaccine efficacy. Nevertheless, molecular programs associated with DENV-specific CD8 + T cell subsets have not been defined. Here, we studied the transcriptomic profiles of human DENV-specific CD8 + T cells isolated after stimulation with DENV epitopes from donors who had been infected with DENV multiple times and would therefore be expected to have significant levels of adaptive immunity. We found that DENV-specific CD8 + T cells mainly consisted of effector memory subsets, namely CD45RA − CCR7
− effector memory (Tem) and CD45RA + CCR7 − effector memory re-expressing CD45RA (Temra) cells, which enacted specific gene expression profiles upon stimulation with cognate antigens. DENV-specific CD8 + T cell subsets in general, and Temra cells in particular, were fully activated and polyfunctional, yet associated with relatively narrow transcriptional responses. Furthermore, we found that DENV-specific CD8 + Tem and Temra cells showed some unique T cell receptor features in terms of overlap and variable (V) gene usage. This study provides a transcriptomic definition of DENV-specific activated human CD8 + T cell subsets and defines a benchmark profile that vaccine-specific responses could aim to reproduce.
Dengue-specific CD8 + T cell subsets display specialized transcriptomic and TCR profiles T cells, the vast majority of IFN-γ + CD8 + T cells in the DENV megapool-stimulated group displayed either a CD45RA -CCR7 -effector memory T (Tem) or a CD45RA + CCR7 -effector memory T re-expressing CD45RA (Temra) phenotype ( Figure 1C ), also consistent with a previous report (19 Figure  2E ). DE genes that resulted from these comparisons can be found in Supplemental Table 2 . As expected, IFNG and many genes associated with activation and effector functions, such as CD69, CD160, CRTAM, SLAMF7, TNFRSF9, TNF, CCL3, CCL4, and GZMB, were upregulated in both DENV IFN-γ + Tem and Temra cells ( Figure 2 , B and C, and Supplemental Table 2 ). Additionally, the expression of several costimulatory molecules, such as CTLA4 and TNFSF14, as well as transcription factors such as EGR1, EGR2, EGR3, IRF4, and IRF8 was also increased in DENV IFN-γ + Tem and Temra cells (Figure 2 , B and C, and Supplemental Table 2 ). Since CD8 MP-stimulated IFN-γ -CD8 + T cell subsets were exposed to the DENV-derived epitopes similarly but did not respond to stimulation, they could serve as another transcriptomic baseline in addition to unstimulated CD8 + T cell subsets. (33, 34) . A subset of CD4 + Temra cells has a highly specialized gene expression program and acquires the expression of cytotoxic molecules (33, 34) , highlighting the general concept that T cell differentiation can result in downregulation of "irrelevant" programs and/or acquisition of new or enriched gene expression programs. However, whether the differentiation of CD8 + Temra cells also results in similar gene expression patterns is not known.
In this study, we isolated and systematically characterized the immune signatures of DENV-specific CD8 + T cell subsets after stimulation with DENV epitopes. Our data show that DENV-specific CD8 + T cells predominantly consist of Tem and Temra cells, which upregulated the expression of gene modules associated with activation, costimulation, and effector functions. The gene expression patterns of DENV-specific CD8 + T cells, especially Temra cells, are associated with relatively narrow transcriptional responses, suggesting that the differentiation of antigen-specific CD8 + T cell subsets is associated with a focused and specialized approach.
Results

DENV-specific CD8
+ T cells are predominantly Tem and Temra. To investigate the phenotypic and functional characteristics of DENV-specific CD8 + T cells, we focused on cells identified by the production of IFN-γ after stimulation with a previously defined pool of over 268 CD8 DENV epitopes (35) , which allows for broad coverage of DENV responses, irrespective of HLA type and DENV serotype, and is referred to hereafter as the DENV megapool (CD8 MP). This strategy was put in place based on previous observations that indicated that the majority of DENV-specific CD8 + T cells are strong producers of IFN-γ and thus could be detected ex vivo (19) .
A series of previous studies from our group characterized DENV-specific CD8 + T cell responses in the context of natural immunity in populations heavily exposed to DENV (18, 19, 35) . Here, following a similar approach, plasma samples from normal blood donors from the general hyperendemic population of the Colombo region in Sri Lanka were screened for high neutralizing titers against multiple DENV serotype, reflective of previous multiple DENV infections. PBMCs from donors that had been infected with DENV multiple times were stimulated with the DENV megapool, and the memory phenotype of these DENV-specific CD8 + T cells was determined by the expression of the commonly used memory markers CD45RA and CCR7. Gating strategies and FACS profiles for a representative donor are shown in Figure 1A .
In a total of 6 donors analyzed, the frequency of IFN-γ + CD8 + T cells ranged from 0.05% to 5.19% with a median value of 0.36% after unstimulated control responses were subtracted ( Figure 1B ). This relatively wide range is consistent with previous results (35) , and might reflect variations in the previous infection history and time from infection, which is unknown for the blood bank donors analyzed in this study. Figure 2 , B and C, and Supplemental Table 2 (Supplemental Figure 2, A and B) . Moreover, the overlapping genes include genes such as IFNG, CD69, CRTAM, SLAMF7, TNFRSF9, TNF, CCL3, CCL4, GZMB, CTLA4, EGR1, EGR2, EGR3, IRF4, and IRF8 as described above (Supplemental Figure 2 , C and D, and Supplemental Table 3 ). Moreover, the fold changes of these overlapping genes were highly correlated between these two approaches (Supplemental Figure 2, C and D) .
We next identified differentially expressed genes between unstimulated Tem and unstimulated Temra cells and found that Temra cells had enhanced expression of the transcription fac- + Tem cells, respectively, we found that only 6 genes, including KIR2DL3 and KIR3DL1, were shared by these 2 lists of DE genes. In contrast, 79 genes were found to be specific for unstimulated Temra cells, whereas 98 were specific for DENV-specific Temra cells ( Figure 2F and Supplemental Table 4 
Identifying gene modules that can discriminate between different CD8
+ T cell populations. The data presented above suggest that CD8 + Temra cells have a more focused and selective pattern of gene expression than their Tem counterpart; this finding is more pronounced in antigen-specific T cells. We reasoned that this might be reflective of the activation of specific gene modules, encompassing genes that are coordinately expressed in the different T cell subsets. Accordingly, to better understand the biological functions associated with those DE genes, we performed weighted gene coexpression network analysis (WGCNA) (37, 38) . Figure 3A depicts the analytic strategy. Briefly, we filtered out low-expressed genes with a median transcripts per million (TPM) value of less than 10 in all of the 4 cell populations. We identified 12 gene modules that were associated with statistically significant differences in least 1 of the 4 pairwise comparisons. The associated P values and the number of genes in each module are listed in Table 1 . These 12 gene modules contained a total of 360 DE genes, which are listed in Supplemental Table 5 and were visualized on a heatmap as shown in Figure 3B .
We observed that there were 7 and 4 gene modules that could significantly distinguish DENV IFN-γ + Tem and Temra cells from their unstimulated counterparts, respectively, and that 2 clusters (blue and magenta) were significant in both comparisons ( Table  1 ). The blue, yellow, purple, tan, turquoise, and dark gray modules mainly discriminate between unstimulated and DENV IFN-γ + Tem and/or Temra cells and contained activation-and effector --associated genes such as CCL4, TNFRSF9 (encodes CD137), CCL3, IFNG, GZMB, CRTAM, TNF, LAG3, NFKBIZ, and HAVCR2 (encodes Tim-3). Additionally, several transcription factors such as BCL2, ID2, IRF8, and IRF4 and genes involved in T cell migration such as SLAMF7 and S1PR2 were also found in these clusters.
We found that the blue, tan, magenta, salmon, orange, and pink modules were statistically distinct between unstimulated Tem and Temra cells when these 2 populations were compared directly (Table 1) . Notably, the salmon and pink modules were statistically significant only in this comparison and contained genes such as CD28 and CD83, which are involved in T cell activation. In contrast, the gray, green, and black modules distinguished DENV IFN-γ + Tem and Temra cells (Table 1) , and DENV IFN-γ + Temra cells largely downregulated the genes contained in the green and black modules ( Figure 3B ). Thus, stimulation with DENV epitopes changes the differences between responding CD8 + Tem and Temra cells. These data further emphasize that a crucial difference between CD8 + Tem and Temra cells is the degree of selectivity in the pattern of gene expression, especially following antigen-specific stimulation.
Validation of differentially expressed genes by CyTOF. To validate the mRNA expression signatures of unstimulated and DENV IFN-γ + CD8 + Tem and Temra cells, we used an independent set of donors and performed cytometry by time-of-flight (CyTOF) analysis on selected DE genes that were contained in the gene modules identified in Figure 3 and for which antibodies were commercially available. Owing to limited antibody availability for the genes that could discriminate DENV IFN-γ + Tem and Temra cells, most of the molecules analyzed in Figure 4 Figure 4 show the contribution of individual markers to this difference and indicate the P values specific to each marker (comparisons used the 2-tailed Wilcoxon test, not corrected for multiple comparisons in order + T cells were measured simultaneously, and 2-dimensional maps of the resulting high-dimensional data were generated by visualization of stochastic neighbor embedding (viSNE) (39) . While Tn cells were arranged largely in one area of the map, Tcm and especially Tem and Temra cells displayed a broader distribution and were grouped into several distinct islands, suggesting that these memory subsets were heterogeneous and could be further divided into dynamic subpopulations ( Figure 5A) . Notably, IFN-γ + DENV-specific CD8 + T cells formed a and Temra cells showed preferential usage of certain TRBV genes. For example, TRBV7-9 was expanded and overrepresented in both DENV-specific Tem and Temra cells in donor GS1149, whereas TRBV7-8 was predominantly used by DENV-specific CD8 + T cells, especially Tem cells, in donor GS1180 ( Figure 6C ). Intriguingly, in donor GS1188, TRBV9 was the single most predominant TRBV segment in DENV-specific Temra cells, whereas DENV-specific Tem cells were less biased, with TRBV4-3 being the most overrepresented TRBV segment in those cells ( Figure 6C ). Taken together, these data suggest that CD8 + Temra cells tend to have more biased TCR repertoires than Tem cells and that DENV-specific CD8 + Tem and Temra cells show both common and distinct TRBV gene usage in their TCR repertoires.
Discussion
This study is, to our knowledge, the first systematic analysis of isolated human virus-specific CD8 + memory T cell subsets, namely Tem and Temra cells. The current study built on previously published results implicating that CD8 + Tem and Temra cells are important in protection against viral pathogens and further characterized these CD8 + T cell subsets at the transcriptomic level, but it does not directly address protection. Our data show that the transcriptional profiles of antigen-specific CD8 + T cell subsets are highly different from those of unstimulated ones, thus highlighting the value of our approach and demonstrating that sequencing of bulk non-antigen-specific T cells alone will miss important determinants of the molecular programs. We further found that the differentiation of DENV-specific CD8 + T cell subsets, especially Temra cells, is associated with narrowing the transcriptional program and TCR repertoires program. The secondary donors studied here were from endemic areas and had been infected with DENV multiple times; therefore, it is expected that they had developed, at least to some extent, natural immunity from severe disease (43) . These results could help guide the development of effective vaccines by providing a benchmark that vaccine-specific response could aim to replicate. According to the current study, a vaccine that elicits a strong CD8 + Temra response and specifically activates molecules such as CCL3/CCL4, CD69, CRTAM, IFN-γ, TNF-α, CTLA4, ICOS, LIGHT, IRF4, IRF8, SLAMF7, and KIR2DL3 would be expected to be of particular interest. Moreover, to our knowledge, this is the first transcriptomic profiling of isolated human antigen-specific CD8 + T cell subsets following stimulation with cognate antigen. The results have general implications for our understanding of the differentiation and activity of CD8 + T cell subsets.
The current study provides several insights into the gene expression profiles of unstimulated bulk versus DENV-specific CD8 + T cell subsets. Our data systematically characterized the immune signatures of DENV-specific CD8 + T cell subsets, and the expression of numerous genes was confirmed at the protein level by cytometry by time-of-flight (CyTOF). Collectively, the data indicate that CD8 + Temra cells have a more focused and selective gene expression pattern than Tem cells.
First, we showed that the majority of IFN-γ-producing CD8 + T cells in response to DENV epitopes display a Tem or Temra phenotype. Second, we identified genes that are upregulated in both DENV-specific Tem and Temra cell populations distinct island and mainly consisted of Tem and/or Temra subsets with the relative proportion of these 2 subsets varying between donors ( Figure 5A ). Furthermore, within the island of IFN-γ + cells, some molecules, such as CCL3 and CD69, showed clustered expression, while others, such as CTLA4, TNF-α, IRF4, and IRF8, displayed a gradient or mixture of expression ( Figure 5B Figure 6A ). Likewise, there was a nonsignificant trend (adjusted P value = 0.1014 with Dunn's multiple-comparisons test; Figure 6A ) for DENV-specific CD8 + Tem cells to have less diverse TRB repertoires compared with unstimulated Tem cells. The diversity of DENV IFN-γ + Temra cells was similar to that of unstimulated Temra cells. Additionally, no significant difference was observed between DENV-specific CD8 + Tem and Temra cells ( Figure 6A ). The overall P value determined by Friedman test was 0.0228, and unstimulated Tem versus DENV IFN-γ + Tem and unstimulated Tem versus unstimulated Temra were the 2 biggest contributors to this overall significance. Thus, these data may suggest that Tem cells may undergo clonal expansion in response to DENV antigens and that the Temra subset may mainly consist of highly clonally expanded cells.
We next evaluated the overlap of TRB repertoires by computing the normalized number of shared clonotypes using CDR3 amino acid sequences as previously described (42) . This analysis revealed that the degree of overlap was higher between DENV-specific and unstimulated Temra cells compared with DENV IFN-γ Furthermore, we performed analysis of TRBV segment usage that revealed large variations between individual donors ( Figure  6C and Supplemental Table 6 ), which was in line with the diverse MHC class I alleles of the cohort (Supplemental Table 1 ). Temra cells tend to have a narrower distribution in their TCR repertoires than Tem cells, as Temra cell TCR repertoires consisted of fewer segments than their Tem counterparts in 5 of the 6 tested donors ( Figure 6C) . Notably, in some donors DENV-specific CD8 + Tem One distinctive aspect of this study is the integration of transcriptional and phenotypic profiling with TCR analysis. Our analysis of TRB repertoire overlap between CD8 + T cell subsets reveals that DENV-specific CD8 + Tem and Temra cells have the highest degree of overlap. Thus, it is possible that some DENV-specific Tem and Temra cells may share certain CDR3 sequences as previously observed for HCMV-specific CD4 + Tem and Temra cells (50) . Since Temra cells also have a more specialized gene expression profile, we speculate that some Temra cells may derive from Tem cell clones and then undergo clonal expansion and differentiation. We further analyzed the usage of TRBV segments in individual donors and observed that DENV-specific CD8 + Tem and Temra cells have preferential usage of certain TRBV genes particularly in some of the donors. Because of the variation in MHC class I alleles between donors in the cohort, we did not observe a single TRBV segment that is overrepresented in 2 or more donors. Nevertheless, 2 TRBV7 subgroup members, TRBV7-9 and TRBV7-8, are preferentially used by DENV-specific Tem and Temra cells in donors GS1149 and GS1180, respectively, and the 2 donors share 2 MHC class I alleles, HLA-B*35:03 and HLA-C*04:01. A few TRBV segments, including TRBV11-2, TRBV9, and TRBV12-3/4, have been reported to be commonly represented in HLA-A*11:01-restricted CD8 + T cells that are specific for the nonstructural protein epitope NS3 133 variants derived from DENV1, DENV3, and DENV4 (51) . Notably, TRBV9 was also overrepresented in DENV-specific Tem and, to a much larger extent, Temra cells in donor GS1188, who possessed the HLA-A*11:01 allele. Thus, this study extends previous findings and further reveals the similarities and differences between DENV-specific Tem and Temra subsets in terms of their TCR features.
As total DENV-specific IFN-γ + CD8 + T cell subsets were sorted and analyzed in the current study, one cannot rule out the possibility that protection against DENV is mediated by a subpopulation(s) harboring a specific TCR(s) instead of being mediated to a single gene/factor that may determine the generation of CD8 + Tem or Temra cells. Additionally, the differentiation of CD8 + Tem and Temra cells is not unique to DENV infection, and we do not know whether the differentially expressed genes observed in the current study would also apply to other viruses. , are highly activated and upregulate genes associated with T cell activation, proliferation, cytotoxicity, and migration (27) . In this study, we further isolated DENV-specific CD8 + T cells via their production of IFN-γ in response to a comprehensive pool of CD8 + T cell epitopes derived from DENV. Moreover, we identified and analyzed DENV-specific Tem and Temra cells separately. Although our samples were collected from secondary DENV-infected donors who were healthy at the time of sample collection, we found that DENV-specific CD8 + Tem and/or Temra cells still upregulated many of the genes reported by Chandele et al., such as XCL1, GZMB, CTLA4, HAVCR2, LAG3, and CD160, suggesting that DENV-specific CD8 + T cells may maintain an activated differentiated state even at convalescent stage in donors that have been infected with DENV multiple times. Thus, these cells may respond rapidly and exert effector functions on DENV reinfections.
It has been previously shown that CD4 + Temra cells are heterogeneous and that GPR56-expressing Temra subpopulations have a specialized gene expression program characterized by the upregulation of cytotoxic molecules (33, 34) . Consistent with these previous findings on CD4 + Temra cells, this study shows that CD8 + Temra cells also display a more focused and specialized gene expression profile than Tem cells. Pairwise comparisons between unstimulated Tem and Temra cells as well as between DENV-specific Tem and Temra cells reveal that the number of genes upregulated in Tem cells is much greater than that upregulated in Temra cells. It is likely that many active genes gradually reduce expression in Temra cells as they progress toward a more specialized differentiation state. In line with this notion, we found that CD8 + Temra cells have enhanced expression of several KIRs at the mRNA level, which is consistent with a previous report (44) . Although KIRs are primarily expressed on NK cells, terminally differentiated CD8 + T cells can acquire the expression of KIRs (45) . Furthermore, most KIR-expressing CD8 + T cells display a limited KIR repertoire (45) . Notably, the DENV-specific Temra cell population only upregulate 2 (KIR2DL3 and KIR3DL1) of the 5 KIRs that are upregulated by their unstimulated counterpart, likely manifesting extensive antigen-driven clonal expan- determined by flow cytometry-based neutralization assay (54) and are referred to as secondary DENV infection donors. IFN-γ capture assay and cell sorting for RNA-Seq. Human PBMCs were rested overnight at 37°C in RPMI 1640 medium (catalog RP-21, Omega Scientific Inc.) supplemented with 5% human serum (catalog 100-512, Gemini Bio-Products), 2 mM l-alanyl-l-glutamine (Gluta-MAX-I, catalog 35050061, Thermo Fisher Scientific), 100 U/ml penicillin, and 100 μg/ml streptomycin (catalog 400-109, Gemini BioProducts) and subsequently stimulated with DENV megapool (CD8 MP) (1 μg/ml for individual peptides) or left unstimulated for 3 hours at 37°C. The generation of the CD8 MP was previously described (19) . Briefly, the CD8 MP consisted of 268 epitopes that were selected to account for 90% of the IFN-γ response in both Sri Lankan and Nicaraguan cohorts (18, 19, 35) . The 268 peptides were pooled, lyophilized, and resuspended (1 mg/ml for individual peptides) to form a master mix, which was then used for stimulation. IFN-γ-producing cells were labeled using an IFN-γ Secretion Assay -Detection Kit (catalog 130-054-202, Miltenyi Biotec) according to the manufacturer's instructions. Subsequently, PBMCs were stained with anti-human CD3, CD4, CD8, CD14, CD19, CD45RA, and CCR7 (see Supplemental Table 7 -) cells were sorted into 8 μl of lysis buffer consisting of Triton X-100 (Sigma-Aldrich), recombinant ribonuclease inhibitor (Takara), and dNTP mix (Thermo Fisher Scientific).
HLA-B*35:01 tetramer staining. The source of the tetramers used in this study and tetramer staining were described previously (19) . Briefly, tetramers incorporating eight HLA-B*35:01-restricted DENV epitopes contained in the CD8 MP (HPGAGKTKRY, TPEGIIPTLF, LPVWLAYKVA, TPEGIIPALF, TPEGIIPSMF, VATTFVTPM, IAN-QATVLM, and FTMRHKKATY) were provided by the NIH Tetramer Core Facility. The 8 tetramers were pooled and used to stain PBMCs at a 1:50 dilution for 90 minutes at room temperature. Additional phenotypic markers were added into the mixture after 1 hour. Samples were then acquired using an LSR II flow cytometer (BD Biosciences) and analyzed using FlowJo (Tree Star).
Microscaled RNA-Seq. For each condition, 200 cells were collected at 4°C in 8 μl of lysis buffer composed by 0.2% Triton X-100, 2 U/ μl of recombinant RNase inhibitor (Clontech/Takara), 5 mM dNTP mix (Life Technologies) in a 0.2-ml PCR tube (MAXYMum Recovery, Axygen). Right after sorting, tubes were vortexed at medium speed, spun for 5 minutes at more than 2000 g, and stored at -80°C until the completion of the whole set of samples. Four microliters of each sample was amplified following the Smart-seq2 protocol (55, 56) . Briefly, mRNA was captured using poly-dT oligonucleotides and directly reverse-transcribed into full-length cDNA using the described template-switching oligonucleotide (55, 56) . cDNA was amplified by PCR for 18 cycles and purified using AMPure XP magnetic beads (0.9:1 [vol/vol] ratio; Beckman Coulter). From this step, for each sample, 1 ng of cDNA was used to prepare a standard Nextera XT sequencing library (Nextera XT DNA library prep kit and index kits, Illumina). Barcoded Illumina sequencing libraries (Nextera, Illumina) were generated using an automated platform (Biomek FXP, Beckman Coulter). Both whole-transcriptome amplification and sequencing library preparations were performed in a 96-well format to reduce assay-to-assay homogeneously by the entire DENV-specific IFN-γ + CD8 + T cell populations. It would be interesting to investigate whether or not such subpopulations with a specific TCR would display a mainly Temra phenotype.
Our data showed that there was no significant difference between unstimulated Temra and DENV-specific Temra cells in terms of the diversity of their TCR repertoires. This might be partially due to the fact that the TCR repertoires of stimulated DENV-specific Temra cells might already be enriched in the unstimulated Temra population in those donors as they have been infected multiple times with DENV. While Temra cells might be an important component of the potent adaptive immune response against DENV, additional studies are needed to clarify the specific roles of this subset in protecting against DENV and address how this subset functionally compares with Tem cells during DENV infection. Clearly, the establishing of functional correlates of DENV-specific CD8 + T cell subsets is hampered by the fact that murine models of DENV infection are limited and that Temra cells are only defined in humans, not in mice. Additional insights would be provided by extensive investigation of the correlation between the activity of DENV-specific Tem and Temra cells during acute DENV infection and disease outcomes, which is beyond the scope of the current study.
One remaining issue is whether the magnitude of DENVspecific CD8 + T cell response correlates with neutralization antibody titers. Clearly, the number of data points in the current study is not suited to establish a meaningful correlation, but can be inspected for trends to be followed up in future studies. Although our study was not designed to address this question, based on the 6 donors used for RNA-Seq, we found that 3 of the 3 donors with a higher response magnitude (>0.3% IFN-γ + CD8 + T cells in response to DENV epitopes) had a median neutralization antibody titer greater than 500. In contrast, only 1 of the 3 donors with a low response magnitude (<0.3% IFN-γ + CD8 + T cells in response to DENV epitopes) had a median neutralization antibody titer greater than 500. Future studies are needed to investigate whether DENV-specific CD8 + T cell responses are correlated with neutralizing antibody responses.
In summary, our data show that the differentiation program of human DENV-specific CD8 + T cell subsets, especially Temra cells, while being activated and polyfunctional, is associated with narrow transcriptional responses and TCR repertoires, and thus a more focused and specialized approach. These findings reveal immune signatures of human DENV-specific CD8 + Tem and Temra subsets and may have broad implications for understanding the differentiation of antigen-specific CD8 + T cell subsets.
Methods
Human blood samples. Blood samples from healthy adult blood donors of both sexes between the ages of 18 and 65 were collected anonymously by the National Blood Center, Ministry of Health, Colombo, Sri Lanka, between 2010 and 2016 and processed at the Genetech Research Institute as previously described (52) . The details of the donors used in this study are listed in Supplemental Table 1 . Serology. DENV seropositivity was determined by anti-DENV IgG ELISA as previously described (53 with the viability marker cisplatin followed by a surface antibody cocktail. Subsequently, cells were fixed in PBS with 2% paraformaldehyde overnight at 4°C. The following day, cells were stained with an intracellular/intranuclear antibody cocktail after fixation and permeabilization using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience). Before sample acquisition, cellular DNA was labeled with Cell-ID Intercalator-Ir (Fluidigm). Samples were then acquired using a Helios mass cytometer (Fluidigm). Antibodies used in CyTOF are listed in Supplemental Table 8 . Visualization of stochastic neighbor embedding (viSNE) analysis of CyTOF data was conducted using Cytobank (66) . TCR analysis. MiXCR v2.1.5 (40, 41) was used to extract TCR β chain CDR3 repertoires from RNA-Seq data of sorted T cell subsets. Subsequent TCR β chain diversity and repertoire overlap analyses were performed using the tcR R package v2.2.1.7 (67), and gene usage was analyzed using VDJtools v1.1.7 (68) .
Data availability. The RNA-Seq data were deposited in the NCBI's Gene Expression Omnibus (GEO) database under the accession code GSE116957 and ImmPort under the study number SDY 888.
Statistics. Two-tailed Mann-Whitney (unpaired), Wilcoxon (paired), Friedman (paired), or 2-way ANOVA test was used to determine statistical significance between groups using Prism software (GraphPad). Šidák's and Dunn's multiple-comparisons tests were performed using Prism software. Statistical significance of gene modules was determined by 2-tailed paired Student's t test.
Study approval. The institutional review boards of both the La Jolla Institute for Immunology and the Medical Faculty, University of Colombo (serving as the NIH-approved Institutional Review Board for Genetech), approved all protocols described in this study. Please note that Sri Lankan blood samples were discarded buffy coats from routine blood donations at the National Blood Center and thus were exempt from human subject review as suggested by the institutional review boards.
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RNA-Seq analysis. The single-end reads that passed Illumina filters were filtered for reads aligning to transfer RNA, rRNA, adapter sequences, and spike-in controls. The reads were then aligned to UCSC hg19 reference genome using TopHat v1.4.1 (57) . DUST scores were calculated with PRINSEQ Lite v0. 20.3 (58) , and lowcomplexity reads (DUST > 4) were removed from the BAM files. The alignment results were parsed via SAMtools (59) to generate SAM files. Read counts to each genomic feature were obtained with the htseq-count program (60) using the "union" option. After removal of absent features (zero counts in all samples), the raw counts were then imported to DESeq2 v1.16.1 to identify differentially expressed genes between groups (61). Paired DE analysis was performed using a multifactor design that includes the donor information as a term in the design formula in DESeq2, which accounts for differences between the donors. Wald test P values were adjusted for multiple testing using the Benjamini-Hochberg procedure (62) , and genes with an adjusted P value less than 0.05 and a shrunken log 2 fold change greater than 1 or less than -1 were considered significantly differentially expressed between groups.
Transcripts per kilobase million for a given gene i in a given sample was calculated as follows: TPM i = 10 is the sum of the rate of reads per kilobase for all the genes present in the sample. Genes with a median TPM value less than 10 in all of the 4 cell groups were excluded (63) . The Web tool Enrichr (http://amp.pharm.mssm.edu/Enrichr/) was used to perform gene ontology (GO) biological processes enrichment analysis (64, 65) . Fisher exact test was used to assess the significance of the enrichment, and biological processes with an adjusted P value less than 0.05 were considered significant.
Coexpression and clustering analysis. Weighted gene coexpression network analysis (WGCNA) was performed to identify sets of genes that share a similar expression pattern (37, 38) . Genes with a median TPM value less than 10 in all of the 4 cell groups were excluded from the WGCNA analysis (63) . A total of 31 coexpression modules were identified by WGCNA. The gene expression profile of a module was summarized by module eigengene, which is defined as the principal component of the module (37, 38) . To determine which modules could discriminate between 2 given cell groups, we compared the module eigengene values between samples from each of the 2 given cell groups. Since each donor contributed 1 sample to each of the cell groups, we performed a paired t test and considered a P value of ≤0.05 as statistically significant. To further enrich the selected modules with genes that have a high "discriminatory" power, only those genes identified in differential expression analyses were retained (for the cases in which the module achieved significance). In addition, only DE genes with high intramodular connectivity (membership ≥0.5) were included.
